ArticleTrials2024

A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial.

Charlotte Andriessen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.